S H Kelkar & Company Ltd (Chemicals - Others) — fundamental analysis, earnings data, and key metrics. PE: 17.8. ROE: 7.7%. This stock is not currently in the Nifty 500 momentum outperformers list.
Deep value thesis based on recent earnings • Updated Mar 7, 2026
S H Kelkar is showing early signs of recovery with revenue growth accelerating to 7.5% YoY in Q3 FY26 (₹583.8 crore), PBT surging 79.2% YoY to ₹49 crore, and a dramatic 449.5% YoY improvement in 9M PBT to ₹97.8 crore, driven by margin recovery initiatives and strategic investments in global markets that could unlock value as operational efficiencies materialize.
Verdict
EARLY_INNINGS
Re-rating catalysts over the next 2-4 quarters • Updated Mar 7, 2026
Cost optimization initiatives expected to reverse 229 bps YoY margin compression, targeting OPM expansion to 12%+ by year-end
“Management commentary on financial discipline and working capital efficiency in Q3 earnings call”
Improved cash flows from operational turnaround expected to reduce D/E from current 0.67x to 0.5x within 6 months
“G CFO's statement on strengthening financial discipline and improving cash conversion”
Strategic US expansion expected to drive premium valuation as global footprint diversifies revenue base
Impact: +₹87.5 Cr revenue
“Management's focus on long-term strategy and global footprint expansion mentioned in Q3 results”
Risks that could prevent re-rating or deepen the value trap
Continued input cost inflation or pricing pressure in specialty chemicals sector
Impact: -200 bps margin impact
Management view: Management acknowledges margin pressures but believes cost optimization will reverse trend by Q4 FY26
Monitor: Quarterly OPM trend and input cost data
Further inventory buildup or receivables deterioration
Management view: Management focusing on working capital efficiency as stated in Q3 earnings call
Monitor: Operating cash flow to revenue ratio and DSO/DIO trends
Forward-looking targets from management for FY27
Revenue Growth Target
10%
Implied PAT Growth
35%
OPM Guidance
12%
Capex Plan
₹150 Cr
Key Milestones
• Margin recovery to 12%+ OPM by Q4 FY26
• US market contribution reaching 15% of revenue by Q2 FY27
The above analysis is AI-generated from publicly available financial data. This is educational research only — not investment advice. Last updated Mar 7, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
S H Kelkar & Company Ltd's latest quarterly results (Dec 2025) show
S H Kelkar & Company Ltd's current PE ratio is 17.8x.
S H Kelkar & Company Ltd's price-to-book ratio is 1.2x.
S H Kelkar & Company Ltd's fundamental strength based on key financial ratios
S H Kelkar & Company Ltd has a debt-to-equity ratio of N/A.
S H Kelkar & Company Ltd's return ratios over recent years
S H Kelkar & Company Ltd's operating cash flow is positive (FY2025).
S H Kelkar & Company Ltd's current dividend yield is 0.84%.
S H Kelkar & Company Ltd's shareholding pattern (Dec 2025)
S H Kelkar & Company Ltd's promoter holding has remained stable recently.
S H Kelkar & Company Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
S H Kelkar & Company Ltd has 3 key growth catalysts identified from recent earnings analysis
S H Kelkar & Company Ltd has 2 key risks worth monitoring
S H Kelkar & Company Ltd's management has provided the following forward guidance for FY27
Based on quantitative research signals, here is why S H Kelkar & Company Ltd may be worth studying
S H Kelkar & Company Ltd investment thesis summary:
S H Kelkar & Company Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
